---
figid: PMC7662576__fmed-07-572485-g0004
figtitle: Host targeted drugs with potential use for Coronavirus disease-19 and their
  proposed mechanism of action
organisms:
- NA
pmcid: PMC7662576
filename: fmed-07-572485-g0004.jpg
figlink: pmc/articles/PMC7662576/figure/F4/
number: F4
caption: Host targeted drugs with potential use for Coronavirus disease-19 and their
  proposed mechanism of action. (A) Anakinra, is a human Interleukin 1 receptor antagonist,
  and tocilizumab is a monoclonal antibody that binds to IL-6 receptors (, ); (B)
  Azithromycin inhibits phosphorylation of S6RP in the mTOR pathway in T cells, which
  leads to reduced cell growth, protein synthesis, and increased apoptosis and autophagy
  of T cells (); (C) Immunomodulating effects of chloroquine and hydroxychloroquine,
  which inhibits the production of IL-1, IL-1β, IL-6, and TNFα (, , ); (D) Baricitinib
  inhibits the activation of different interleukins and growth factors through inhibiting
  the JAK1 and JAK2 on the cytokine receptor (–). The figure was created with Biorender.com.
papertitle: 'Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association
  for Infectious Diseases and Immunological Disorders (Waidid).'
reftext: Bahaa Abu-Raya, et al. Front Med (Lausanne). 2020;7:572485.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9249281
figid_alias: PMC7662576__F4
figtype: Figure
organisms_ner:
- Danio rerio
- Homo sapiens
redirect_from: /figures/PMC7662576__F4
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7662576__fmed-07-572485-g0004.html
  '@type': Dataset
  description: Host targeted drugs with potential use for Coronavirus disease-19 and
    their proposed mechanism of action. (A) Anakinra, is a human Interleukin 1 receptor
    antagonist, and tocilizumab is a monoclonal antibody that binds to IL-6 receptors
    (, ); (B) Azithromycin inhibits phosphorylation of S6RP in the mTOR pathway in
    T cells, which leads to reduced cell growth, protein synthesis, and increased
    apoptosis and autophagy of T cells (); (C) Immunomodulating effects of chloroquine
    and hydroxychloroquine, which inhibits the production of IL-1, IL-1β, IL-6, and
    TNFα (, , ); (D) Baricitinib inhibits the activation of different interleukins
    and growth factors through inhibiting the JAK1 and JAK2 on the cytokine receptor
    (–). The figure was created with Biorender.com.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - kita
  - ngfra
  - ighv1-1
  - cd4-1
  - mtor
  - il6
  - tnfa
  - tnfb
  - jak1
  - jak2b
  - CD4
  - CD14
  - NDUFA2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - IL1B
  - IL6
  - IL12A
  - IL12B
  - IL2
  - IL37
  - IL23A
  - TNF
  - IL18
  - JAK1
  - JAK2
  - GLI2
  - Azithromycin
  - Chloroquine
  - Hydroxychloroquine
  - Baricitinib
  - Coronavirus
---
